Gene · 6421
NIH grants1,450
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,101 to 1,120 of 1,450
Download this page as JSON| Grant | Title | SFPQ papers | Newest fiscal year |
|---|---|---|---|
| R01DK064240 | Preservation of mucosal barrier in surgical diseases | 1 | 2014 |
| R01GM040505 | Phosphorylation and Functions of the RNA Polymerase CTD | 1 | 2014 |
| R01GM047867 | Mechanisms of Transcriptional Regulation in Chromatin | 1 | 2014 |
| R01GM073894 | The chromatin response in mammalian double strand break repair | 1 | 2014 |
| R01GM090247 | Structure/Function Studies of Mammalian Circadian Clock Proteins | 1 | 2014 |
| R01GM095501 | New Approaches for the Delivery of Proteins and Nucleic Acids Into Cells | 1 | 2014 |
| R01GM095599 | Defining the human telomere signaling networks and their implication in cancer | 1 | 2014 |
| R01MH084880 | Comprehensive analysis of the FMR1 locus transcriptional landscape | 1 | 2014 |
| R01MH090127 | Biobehavioral Role of Brain Kynurenine Metabolism in Mental Illness | 1 | 2014 |
| R01NS064945 | Neuroprotection by a Nuclear Carbonic Anhydrase in C. elegans | 1 | 2014 |
| R03CA172847 | The role of miR-211 and its target genes in melanoma development in humans. | 1 | 2014 |
| R03CA177954 | Modulation of p53 induction by targeting cap-dependent translation in cancer | 1 | 2014 |
| R21CA178860 | Development of deep proteomic sequencing platforms for molecular markers in DLBCL | 1 | 2014 |
| R21NS083967 | Role of Vimentin in Pathogenesis of CNS Inflammation | 1 | 2014 |
| R37CA036401 | PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL) | 1 | 2014 |
| R56AI110985 | Regulation of Hematopoiesis By Ribosomal Protein Paralogs | 1 | 2014 |
| R56NS061867 | Peptide and Protein Biomarkers for Amyotrophic Lateral Sclerosis (ALS) | 1 | 2014 |
| T32NS007484 | Fundamental Neurobiology | 1 | 2014 |
| U01CA152758 | MiRNAs/UCRs: biomarkers for cancer risk, tumor detection, progression & treatment | 1 | 2014 |
| U01GM061393 | PAAR-Pharmacogenomics of Anticancer Agents Research Group | 1 | 2014 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6421/grants?page=56